Centene Corp updates home health strategy, shares tracked against managed care peers

Centene Corp is reshaping its home health footprint after closing the sale of its subsidiary Paradigm to an Apollo-backed platform, while investors track the managed care company’s shares against UnitedHealth and Elevance in a changing US Medicaid landscape.

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-25, 14:25.

Centene Corp (US15135B1017) is back in focus as investors reassess its shift in home health and complex care services following the sale of its Paradigm subsidiary into an Apollo-backed platform. The managed care group, whose stock trades on the NYSE alongside UnitedHealth and Elevance peers, remains closely watched for how it positions its Medicaid and Medicare Advantage businesses under evolving US policy.

Paradigm sale reshapes complex care footprint

In April 2025 Centene disclosed that it had entered into a definitive agreement to sell Paradigm, a provider of catastrophic and complex care management services, to the parent of One Homecare Solutions, a home health platform backed by Apollo and its affiliates. The transaction, described in the company’s announcement as part of a disciplined portfolio review, moved a specialist business that had been serving high-acuity populations out of Centene’s consolidated operations. Centene’s press release on the Paradigm sale

Paradigm had focused on catastrophic case management and complex claims, including catastrophic workplace injuries and other high-cost clinical situations, and the sale effectively transferred those programs to the One Homecare Solutions platform while leaving Centene to concentrate on its core managed care contracts. Apollo, which controls One Homecare Solutions, sought to build scale across home health and post-acute care services, and Centene’s divestiture aligned with its broader effort to streamline non-core operations and emphasize government-sponsored health plans such as Medicaid, Medicare Advantage and marketplace products.

Operations under pressure from Medicaid redeterminations

The broader operating environment for Centene has been shaped by the US Medicaid redetermination process, which began after the formal end of the COVID-19 public health emergency and has led to large numbers of members losing eligibility across states. UnitedHealth and Elevance have both reported membership declines tied to these redeterminations, a trend that has influenced Centene’s reported membership trends and earnings guidance in recent quarters. Reuters coverage of managed care Medicaid redeterminations

Centene has indicated in recent earnings calls that it is working closely with state partners to manage eligibility transitions and that it continues to focus on improving medical cost ratios through value-based arrangements, care coordination and technology investments. These dynamics make the decision to exit complex care via the Paradigm sale notable, as investors evaluate how Centene balances core Medicaid and Medicare Advantage activities with specialized programs that address the highest-cost patients in its covered populations.

How Centene positions government business

Centene’s core business model revolves around managing government-sponsored health plans, primarily Medicaid managed care, Medicare Advantage and Affordable Care Act marketplace plans, rather than owning hospitals or clinical facilities directly. It contracts with state Medicaid agencies and the federal government, receives per-member-per-month premiums and bears the medical and administrative costs associated with coordinating care, building networks and ensuring compliance with quality metrics and regulatory requirements. Centene’s investor presentation outlining its managed care strategy

The company’s strategy over recent years has been to simplify its portfolio, exit non-core operations such as international businesses and specialty units, and focus capital and management attention on domestic managed care operations where it sees sustainable scale. Earnings presentations have highlighted efforts to improve medical cost ratios, optimize administrative expenses and return capital to shareholders through share repurchases, while continuing to bid for new Medicaid contracts and adjust Medicare Advantage offerings in response to changing CMS reimbursement policies.

What the company sells

Centene sells managed health coverage and related services, primarily through Medicaid managed care, Medicare Advantage and ACA marketplace products, rather than standalone consumer devices. Its revenue is generated from premiums paid by government agencies and individuals, with Centene providing network access, care coordination, pharmacy benefit management and support services to beneficiaries.

Where the stock trades today

Centene Corp shares trade on the NYSE in US dollars; the current live price and exact time stamp were not reliably verifiable at the moment of writing, so investors should consult the NYSE or a real-time quote service for the latest share price.

Centene Corp at a glance

• Company: Centene Corp
• ISIN: US15135B1017
• WKN: A1W8ZS
• Ticker: CNC
• Trading venue: NYSE
• Price (as of 2026-06-25, 14:25): not reliably verified USD
• Market cap: not reliably verified USD (as of 2026-06-25)
• Sector / industry: Health Care - Managed Care
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.